Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life

scientific article published on 01 April 2020

Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S147895151900066X
P698PubMed publication ID31535613

P50authorHanneke PoortQ89932429
P2093author name stringJennifer S Temel
Joseph A Greer
William F Pirl
Jamie M Jacobs
P2860cites workPredictors of fatigue in cancer patients: a longitudinal studyQ91214970
The hospital anxiety and depression scaleQ27860968
Clinically Relevant Four-Level Cancer-Related Fatigue Among Patients With Various Types of CancerQ28074651
Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivorsQ30934359
The validity of the Hospital Anxiety and Depression Scale. An updated literature reviewQ34113060
The Functional Assessment of Cancer Therapy scale: development and validation of the general measureQ34361336
Cancer-related fatigue: the scale of the problemQ34580391
Quality of life: a new perspective for cancer patientsQ34988275
Oral cancer treatment: developments in chemotherapy and beyondQ34998692
Patient education: the cornerstone of successful oral chemotherapy treatmentQ35620471
Overview of the changing paradigm in cancer treatment: oral chemotherapyQ36806145
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled TrialQ36914459
2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapyQ37063671
Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer.Q37192605
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapyQ37385178
The challenges of oral agents as antineoplastic treatmentsQ37868224
Psychotropic medications in patients with cancerQ39679139
The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals.Q41016479
Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study.Q41118725
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).Q42927824
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibQ43675594
Fatigue in advanced cancer: a prospective studyQ46045358
Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors.Q47738372
Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adultsQ47978515
Severe fatigue during the palliative treatment phase of cancer: an exploratory studyQ48253827
Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional studyQ48659321
Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancerQ48662294
Psychopharmacologic applications to cancer. An overviewQ49131666
Predictors of fatigue and work ability in cancer survivorsQ50204669
An Automated Intervention Did Not Improve Adherence to Oral Oncolytic Agents While Managing Symptoms: Results From a Two-Arm Randomized Controlled TrialQ57170285
Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year periodQ57348553
Innovations and Dilemmas in Psychosocial Oncology: Contributions from the 10th Conference of the European Society for Psychosocial OncologyQ57423084
The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue InventoryQ74635584
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G)Q81685445
P433issue2
P304page(s)141-147
P577publication date2020-04-01
P1433published inPalliative and Supportive CareQ15758536
P1476titleFatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life
P478volume18